Group One Trading, L.P. Athenex, Inc. Transaction History

Group One Trading, L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$0.12 - $0.21 $1,511 - $2,644	-12,593 Reduced 29.44%	30,176 $4,000
Q3 2022 Nov 09, 2022	SELL	$0.24 - $1.11 $1,773 - $8,204	-7,391 Reduced 14.73%	42,769 $12,000
Q2 2022 Aug 11, 2022	SELL	$0.41 - $0.91 $26,438 - $58,679	-64,483 Reduced 56.25%	50,160 $21,000
Q1 2022 May 12, 2022	SELL	$0.79 - $1.59 $37,896 - $76,272	-47,970 Reduced 29.5%	114,643 $95,000
Q4 2021 Feb 11, 2022	BUY	$1.36 - $2.94 $221,153 - $478,082	162,613 New	162,613 $221,000
Q2 2021 Aug 10, 2021	SELL	$3.71 - $5.13 $113,036 - $156,300	-30,468 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$4.08 - $14.75 $118,160 - $427,174	28,961 Added 1921.77%	30,468 $131,000
Q4 2020 Feb 10, 2021	BUY	$11.06 - $14.01 $16,667 - $21,113	1,507 New	1,507 $17,000
Q3 2019 Nov 12, 2019	SELL	$12.16 - $21.0 $133,614 - $230,748	-10,988 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$9.44 - $19.8 $103,726 - $217,562	10,988 New	10,988 $218,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.